Lindbrook Capital, LLC - AERPIO PHARMACEUTICALS INC ownership

AERPIO PHARMACEUTICALS INC's ticker is ARPO and the CUSIP is 00810B105. A total of 43 filers reported holding AERPIO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of AERPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$8,000
+300.0%
5,000
+130.3%
0.00%
Q4 2020$2,000
-95.6%
2,171
-92.8%
0.00%
-100.0%
Q3 2020$45,00030,0000.01%
Other shareholders
AERPIO PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
CVI Holdings, LLC 450,676$1,870,0002.33%
SPHERA FUNDS MANAGEMENT LTD. 1,103,554$4,580,0000.63%
Granite Point Capital Management, L.P. 750,000$3,113,0000.28%
Orbimed Advisors 5,193,946$21,555,0000.26%
NEXTHERA CAPITAL LP 298,873$1,240,0000.19%
Artal Group S.A. 1,558,400$6,467,0000.14%
Tekla Capital Management LLC 765,000$3,175,0000.12%
NEVILLE RODIE & SHAW INC 100,000$415,0000.04%
Ascent Wealth Partners, LLC 10,000$41,0000.01%
MOORE CAPITAL MANAGEMENT, LP 100,000$415,0000.01%
View complete list of AERPIO PHARMACEUTICALS INC shareholders